NASDAQ: PMN - ProMIS Neurosciences, Inc.

Altı ay boyunca karlılık: -43.89%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı ProMIS Neurosciences, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils.

daha fazla ayrıntı
The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2007-07-17
ISIN CA74346M4065
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.promisneurosciences.com
Цена ао 0.77
Günlük fiyat değişimi: 0% (0.735)
Haftalık fiyat değişimi: -10.37% (0.82)
Aylık fiyat değişimi: -17.42% (0.89)
3 ayda fiyat değişimi: -21.81% (0.94)
Altı ayda fiyat değişimi: -43.89% (1.31)
Yıllık fiyat değişimi: -64.83% (2.09)
3 yılda fiyat değişimi: +635% (0.1)
5 yılda fiyat değişimi: +332.35% (0.17)
10 yılda fiyat değişimi: 0% (0.735)
Yılbaşından bu yana fiyat değişimi: -18.33% (0.9)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 2.24 7
P/E 0 0
EV/EBITDA 0.2826 10
Toplam: 4.63

Yeterlik

İsim Anlam Seviye
ROA, % -73.22 0
ROE, % -265.68 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 9.6

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 212.45 10
karlılık EPS, % 8.71 2
Toplam: 6.4
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Sphera Funds Management Ltd. 1834042 9.67
Ally Bridge Group (NY) LLC 1066674 5.63
Affinity Asset Advisors, LLC 265958 1.4
Northeast Financial Consultants Inc 100000 0.53
IEQ CAPITAL, LLC 30799 0.16
Fiduciary Trust Company (MA) 20008 0.11
Kingsview Wealth Management, LLC 11100 0.06
Claret Asset Management Corp 10830 0.06
UBS Group AG 5926 0.03
Bank of America Corporation 1666 0.01



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Neil R. Cashman M.D. Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director 333.8k 1952 (73 yıl)
Mr. Gavin T. Malenfant Chief Operating Officer 413.49k 1964 (61 yıl)
Mr. Daniel E. Geffken M.B.A. Chief Financial Officer 89.99k 1957 (68 yıllar)
Dr. Johanne Kaplan Ph.D. Chief Development Officer 263.07k 1960 (65 yıllar)
Dr. Ernest D. Bush Ph.D. Head of Pharmacology/Toxicology & Senior Consultant N/A
Dr. David Wishart Ph.D. Chief Physics Officer N/A
Mr. Dennis Chen Ph.D. Head of Manufacturing & Senior Consultant N/A
Dr. Larry Douglas Altstiel M.D., Ph.D. Chief Medical Officer N/A 1950 (75 yıllar)
Mr. Neil K. Warma M.B.A. President, Interim CEO & Director 40k 1963 (62 yıl)
Mr. Eugene W. Williams Co-Founder & Chairman 1959 (66 yıllar)

Adres: Canada, Toronto. ON MS E, 1920 Yonge Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.promisneurosciences.com